ArticleHaematologica2023
Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.
Alexander P Bye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleHaematologica2023
Alexander P Bye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.